Cyanata Therapeutics

Cynata Therapeutics Limited (ASX: CYP) is a Melbourne-based stem cell and regenerative medicine company that is developing a therapeutic stem cell platform technology, Cymerus™, originating from the University of Wisconsin-Madison, a world leader in stem cell research. The proprietary Cymerus™ technology addresses a critical shortcoming in existing methods of production of mesenchymal stem cells (MSCs) for therapeutic use, which is the ability to achieve economic manufacture at commercial scale.
Bio last updated 04 Apr 2017

Notable People

NamePositionYear Started
Stewart Washer
Stewart Washer
Executive Chair2013
* Most Senior WA Executive

Latest Equity Capital Markets Deals

DateCompanyTransaction TypeTotal Value
23/01/17Cyanata TherapeuticsPlacement$6.0m>>

BNiQ Disclaimer